| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |